Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
GARD collaborating parties
Elisabetta Minelli, Technical Officer
GARD General Meeting
1-2 June 2007
Seoul, Republic of Korea
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Overview
• The power of GARD collaborating parties
• Evolution of number of participants
• Current participants and observers
• Status of parties interested in GARD
• Should GARD keep growing?
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
GARD is
• a voluntary alliance
• of national and international organizations, institutions and agencies
• working towards the common goal of improving global lung health
The power of GARD collaborating parties
StopTB Partnership, WHO
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
WHO vision
Dr Brundtland, Address to WHA
"the global health field has seen
a steady increase in the
number of actors … as WHO,
we must reach out the many
stakeholders – in civil society,
in the private sector and in the
broad health and research
community"
Dr Chan, Address to WHA
One of the sixth-item agenda:
"managing partnerships to get
the best results in countries: (…)
performance within countries
improves when the multiple
activities of partners are
harmonized with national
priorities"
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Overview
• The power of GARD collaborating parties
• Evolution of number of participants
• Current participants and observers
• Status of parties interested in GARD
• Should GARD keep growing?
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
June 2004
WHO
ACAAI
ALAT
ARIA
ATS
EAACI
EFA
ERS
FILHA
FIRS
GA2LEN
GINA
GOLD
NHLBI
WAO
WHO-CC DU
Jan 2005
WHO
AAAAI
AAAF
ACAAI
ARIA
ATS
EAACI
EFA
ERS
FILHA
FIRS
GA2LEN
GINA
GOLD
ICC
INTERASMA
15
21
Oct 2002
WHO
EFA
Jan 2003
WHO
EFA
ARIA
2
3
Evolution of number of participants
KAF
NHLBI
WAO
WHO-CC DU
WHO-CC UCM
WONCA
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
41
2006 General Meeting, BeijingWHO
AAA (D. Vervloet, France)
AAAAI (E. Simon, CAN)
AAAF (R. Pawankar, JAP)
ACAAI (M. Blaiss, USA)
AIMAR (C. Donner, ITA)
ALAT (C. Luna, ARG)
APAACI (T. Fukuda, JAP)
APSR (Y. Fukuchi, JAP)
ARIA (J. Bousquet, FRA)
ATS (P. Wagner, USA)
CNR-INMM (G. Rasi, ITA)
DLHA (DK)
EAACI (U. Wahn, GER)
ECARF (T. Zuberbier, GER)
EFA (S. Palkonen, FIN)
ERS (R. Dahl, DK)
FEMTEC (U. Solimene, ITA)
FILHA (M. Nieminen, FIN)
FIRS (A. Turnbull, SWI)
GA2LEN (P. Van Cauwenberge,
BEL)
GINA (P. O’Byrne, CAN)
GOLD (L. Fabbri, ITA)
ICC (L. Grouse, USA)
INTERASMA (I. Ansotegui,
SPA)
IPRAIS (J. Warner, UK)
IPCRG (A. Ostrem, UK)
KAF (Y. Kim, KOR)
KTL (P. Puska, FIN)
NHLBI (B. Alving, USA)
PSA (P., POL)
RSP (A. Chuchalin, RUS)
SFAIC (G.Pauli, FRA)
SIMER (W. Canonica,ITA)
SPAIC (M. Morais de Almeida)
SPLF (B. Housset, FRA)
The Union (N. Billo, FRA)
TTS (A. Kocabas, TUR)
WAO (C. Baena-Cagnani,
ARG)
WHO-CC DU (S. Makino, JAP)
WHO-CC GU (G. Joos, BEL)
WONCA (A. Loh, SIN)
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
2007 General Meeting, Seoul
WHO
AAA (D. Vervloet)
AAAAI (T. Casale)
AAAF (R. Pawankar)
ACAAI (D. Ein)
AIMAR (C. Donner, ITA)
ALAT (P. Padilla)
ALLERG.O.S (C. Gallen)
APAACI (T. Fukuda)
APSR (Y. Fukuchi)
ARIA (J. Bousquet)
ATS (J. Heffner)
CCM (D. Greco)
CNR-INMM (G. Rasi)
DLHA (B. Hellquist)
EAACI (R. Gerth van Wijk)
ECARF (T. Zuberbier)
EFA (S. Palkonen)
ERS (G.Viegi)
FEMTEC (N. Storozhenko)
FILHA (R. Kauppinen)
FIRS (A. Turnbull)
GA2LEN (P. Van Cauwenberge)
GINA (E. Bateman)
GOLD (S. Buist)
GRA (I. Chkhaidze)
ICC (L. Grouse)
INTERASMA (I. Ansotegui)
IPRAIS (J. Warner)
IPCRG (N. Chavannes)
KAF (Y. Kim)
KTL (P. Puska)
NHLBI (J. Kiley)
PSA (M. Kowalski)
RSP (A. Chuchalin)
SFAIC (P. Scheinmann)
SIMER (G. D'Amato)
SPAIC (M. Morais de Almeida)
SPLF (P. Godard)
THE UNION (N. Billo)
TNSACI (O. Kalayci)
TTS (E. Sabri)
WAO (C. Baena-Cagnani, W.
Canonica)
WHO-CC DU (S. Makino)
WHO-CC GU (G. Joos)
WONCA (A.. Loh)
47
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Overview
• The power of GARD collaborating parties
• Evolution of number of participants
• Current participants and observers
• Status of parties interested in GARD
• Should GARD keep growing?
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Current GARD participants
14
1422
5
2
5 3
Respiratory
Allergy
Primary care
Specific disease
Patient organizations
Govern. institutions
WHO coll. centres
Foundations
Total of 47 participants
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Current observers
Stallergens
Schering Plough Corporation
Sanofi-aventis
Pfizer Inc.
Novartis Pharma
Merck & Co.
GlaxoSmithKline
Chiesi Farmaceutici
Boehringer-Ingelheim
Astra Zeneca
Altana Pharma
11
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Overview
• The power of GARD collaborating parties
• Evolution of number of participants
• Current participants and observers
• Status of parties interested in GARD
• Should GARD keep growing?
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Current status of parties interested in GARD
26
89
31
4 1
Second year DA signed
DA in the process to be
renewed
First DA
In the process of applying
No voluntary contribution
expected
Drop out
78 interested parties
31 in the process of applying Available in your folder
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
New Applicants: Paying
• AIPO, Associazione Italiana
Pneumologi Ospedalieri
• ARF Allergy Research Foundation, UK
• ASC Asthma Society of Canada
• BTS Belgian Thoracic Society
• CTS Canadian Thoracic Society
• EFH Education for Health, UK
• EARS Euro-Asian Society, Republic of
Kazakhstan
• Egypt Society of Allergology and
Immunology
• Egyptian Society of Allergy, Asthma and
Immunology
• IFOS International Federation of Oto-
Rhino-Laryngolocial Societies
• KTS, Kyrgyz Thoracic Society
• JSA Japanese Society of Allergology
• NFAI Norwegian Society of Allergology and Clinical Immunopathology
• PHA Pulmonary Hypertension Association
• SAAAIC Société Algérienned'Asthmologie, d'Allergologie et d'Immunologie Clinique
• SAP Société Algérienne de Pneumophtisiologie
• SLAI Société Libanaise d’Allergie et d’Immunologie
• TSTM Tunisian Society of Thoracic Medicine
• UBSM Union of the Bulgarian Societies of Medicine
• Wyeth Foundation 20
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
New Applicant: Non paying
• CIPA Czech Initiative for Asthma
• IRS International RhinologicSociety
• PTS Pan African Thoracic Society
• Tishreen University - Faculty of Medicine, Syria
• UM 1 University of Montpellier
• CRF Chest Research Foundation, India
• Egyptian Society of Chest Diseases and Tuberculosis
• MSTM Macedonian Society of Thoracic Medicine
• Pakistan Aga Khan University
• RRF Respiratory Research Foundation, India
• YAAC Yugoslav Association for Asthma and COPD
New Applicants: To be decided
5 6
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Overview
• The power of GARD collaborating parties
• Evolution of number of participants
• Current participants and observers
• Status of parties interested in GARD
• Should GARD keep growing?
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Should GARD keep growing?
PROs
• An increasing variety of resources (technical -knowledge, capacities -and financial)
• A higher visibility and recognition in the area of chronic respiratory diseases
• A major strength at the political level
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Should GARD keep growing?
CONs
• Increasing difficulties
in management
• Longer procedures in
the decision-making
process
• Higher risk of sleeping
partners
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Involving new potential partners
according to a plan
• Decision on strategic plan: what the Alliance aims at carrying out
• Analysis of gaps and unmet needs
• Call for new partners in order to fill unmet needs
• Avoid inviting new partners without matching expected outputs and outcome
FIND THE MATCHING PARTNER
Global Alliance against Chronic Respiratory Diseases
www.who.int/gard
Two scenarios
FIRST parties
going to different
directions
without reaching
the goal
SECOND
partners agreeing on a
plan and working
together towards a
common goal